| Autophagy and doxorubicin resistance in cancer |
18 |
| LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling |
17 |
| Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway |
13 |
| Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway |
13 |
| LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway |
12 |
| Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib |
10 |
| Dioscin inhibits colon cancer cells' growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways |
10 |
| MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer |
9 |
| Artemisinin and its derivatives: a potential treatment for leukemia |
8 |
| MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells |
8 |
| FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop |
8 |
| miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1 |
8 |
| Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway |
7 |
| Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells |
7 |
| A case of severe Pembrolizumab-induced neutropenia |
7 |
| Increased miR-203-3p and reduced miR-21-5p synergistically inhibit proliferation, migration, and invasion in esophageal cancer cells |
7 |
| Sonic hedgehog and Wnt/-catenin pathways mediate curcumin inhibition of breast cancer stem cells |
7 |
| Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway |
7 |
| Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich alpha-2-glycoprotein-1 |
6 |
| Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells |
6 |
| 9-ING- a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma |
6 |
| LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144 |
6 |
| Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung |
6 |
| A genome-wide comprehensive analysis of alterations in driver genes in non-small-cell lung cancer |
6 |
| Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells |
6 |
| Histone deacetylase inhibitor BG45-mediated HO-1 expression induces apoptosis of multiple myeloma cells by the JAK2/STAT3 pathway |
6 |
| Discovery of selective inhibitors for cyclic AMP response element-binding protein: a combined ligand and structure-based resources pipeline |
5 |
| Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition |
5 |
| Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer |
5 |
| Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1 |
5 |
| An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F |
5 |
| Hedgehog pathway and smoothened inhibitors in cancer therapies |
5 |
| Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy |
5 |
| Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review |
5 |
| MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression |
5 |
| Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma |
4 |
| Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A |
4 |
| Expression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosis |
4 |
| DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy |
4 |
| Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species |
4 |
| Clinicopathological features and prediction values of HDAC HDAC HDAC and HDAC11 in classical Hodgkin lymphoma |
4 |
| Proapoptotic effects of novel thiazole derivative on human glioma cells |
4 |
| Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo |
4 |
| Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant |
4 |
| Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer |
4 |
| Activation of GPR120 promotes the metastasis of breast cancer through the PI3K/Akt/NF-kappa B signaling pathway |
4 |
| 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy |
4 |
| Osthole inhibits the progression of human gallbladder cancer cells through JAK/STAT3 signal pathway both in vitro and in vivo |
4 |
| LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer |
4 |
| Treatment of pancreatic cancer with intravenous vitamin C: a case report |
4 |
